Fundraising Fox

Viralgen

San Sebastián, ES · 1 known investors

Viralgen provides contract manufacturing services for AAV-based gene therapy, supporting early-phase preclinical and clinical production with a platform designed for regulatory compliance and batch scalability. The company serves gene therapy developers pursuing treatments for rare diseases.

Advanced ManufacturingBiotechDeep TechHealthtechMedical Devices

Founders & leadership

JVJimmy Vanhove
Jimmy VanhoveCEO

Investors · 1

Columbus Venture PartnersValenciavia Jose Mesa · inferred

In the news

AskBio's Viralgen to Supply Commercial-Scale Drug Product for REGENERATE-PD Investigational Gene Therapy Phase II Trial for Parkinson’s Disease - AskBioaskbio.com · Apr 2026AskBio's Viralgen to Supply Commercial-Scale Drug Product for REGENERATE-PD Investigational Gene Therapy Phase II Trial for Parkinson’s Diseaseviralgen.com · Apr 2026Scottish biotech Trogenix raises $95M as brain cancer program nears clinicendpoints.news · Oct 2025

Frequently asked questions

What does Viralgen do?
Viralgen provides contract manufacturing services for AAV-based gene therapy, supporting early-phase preclinical and clinical production with a platform designed for regulatory compliance and batch scalability. The company serves gene therapy developers pursuing treatments for rare diseases.
Who are Viralgen's investors?
Viralgen's investors include Columbus Venture Partners.
Where is Viralgen headquartered?
Viralgen is headquartered in San Sebastián, ES.